Loading
Fetching the latest research
Draft review set — hypertension, heart failure, acute coronary syndromes, CABG, and atrial fibrillation / vascular disease. Each card leads with the engine's verdict; open any to read the full report before publishing.
Randomized clinical trials in hypertension, heart failure, acute coronary syndromes, CABG, and atrial fibrillation / vascular disease, from NEJM · Lancet · Nature Medicine · BMJ (2024–2026) — reviewed by the Αlpha¹ Rigor Review engine for rigor & reproducibility.
1 of these papers was later retracted. Look for the red RETRACTEDband — then read what the engine flagged in the original published text, before any retraction notice.
Mehra MR, Desai SS, Kuy S, Henry TD, Patel AN.
Flack JM, Azizi M, Brown JM, Dwyer JP, Fronczek J, Jones ESW, Olsson DS, Perl S, Shibata H, Wang JG, Wilderäng U, Wittes J, Williams B, BaxHTN Investigators.
How to read this.The engine surfaces specific, verifiable rigor problems — it does notpredict retractions, and a “pass” is not a guarantee of soundness. Papers are analyzed on their published full text with any retraction notice removed, so detection is content-based. Real-world outcome labels (retracted, landmark) are curator-assigned from the public record; the verdict and every surfaced problem are the engine’s own. These are selected examples.